This trial looks at whether itacitinib can help treat patients with sarcomas that haven't responded to other treatments and have spread to other parts of the body. Itacitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
1 Primary · 4 Secondary · Reporting Duration: Up to 2 years
28 Total Participants · 1 Treatment Group
Primary Treatment: Itacitinib · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: